Pancreatic
Disparities in Pancreatic Cancer Outcomes in the Disaggregated Asian American Population
Background:
The Asian American, Native Hawaiian, and Pacific Islander (AANHPI) population is among the fastest-growing population in...
The impact of race/ethnicity on pancreaticoduodenectomy outcomes for pancreatic cancer
Purpose:
To investigate the impact of race/ethnicity on surgical outcomes following pancreaticoduodenectomy for pancreatic cancer.
...
Pancreatic cancer among Pacific Islanders: a comprehensive analysis of an understudied racial group
Objective:
Racial disparities in care and outcome have been demonstrated for several cancers, but it is not clear that a similar dis...
Treatment Inequity: Examining the Influence of Non-Hispanic Black Race and Ethnicity on Pancreatic Cancer Care and Survival in Wisconsin
Introduction:
We investigated race and ethnicity-based disparities in first course treatment and overall survival among Wisconsin pa...
Early-Onset Pancreatic Cancer Increased in White and Hispanic Women
Between 1995 and 2018, non-Hispanic White and Hispanic women in the United States experienced the greatest increases in early-onset pancreatic canc...
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients
Background:
Pancreatic cancer (PC) is a malignancy with a poor prognosis and high mortality. Surgical resection is the only “c...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
